Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 143

Results For "rating"

1828 News Found

Evonik opens its first Zero Liquid Discharge plant in India
Sustainability | May 05, 2022

Evonik opens its first Zero Liquid Discharge plant in India

Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra


DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis
Biotech | May 05, 2022

DNA Script partners with Premas Life Sciences for same-day enzymatic DNA synthesis

This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India


Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit
Biotech | May 04, 2022

Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit

At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes


Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
News | May 04, 2022

Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore

The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings


Foundation S: Sanofi’s new philanthropic spearhead
Sustainability | May 04, 2022

Foundation S: Sanofi’s new philanthropic spearhead

Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer


GOQii launches first of its kind one-stop solution for Diabetes care in India
Startup | May 04, 2022

GOQii launches first of its kind one-stop solution for Diabetes care in India

An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching


Xcardia announces first-in-human use of its new Xtractor device
Biotech | May 02, 2022

Xcardia announces first-in-human use of its new Xtractor device

The announcement follows FDA 510(k) clearance of device


StanPlus appoints Gurjit Singh as COO and Founding Member
People | May 02, 2022

StanPlus appoints Gurjit Singh as COO and Founding Member

He will be leading the business, operations, P&L, and growth strategy for StanPlus


Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Biotech | April 29, 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo


AstraZeneca expands its ‘Young Health Program’ in Delhi
Public Health | April 29, 2022

AstraZeneca expands its ‘Young Health Program’ in Delhi

For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases